Emergent Biosolutions reported $72.9M in Gross Profit on Sales for its second fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Gross Profit On Sales Change
Acadia Pharmaceuticals ACAD:US $ 131.9M 19.38M
ALKERMES ALKS:US 217.86M 5.53M
Alnylam Pharmaceuticals ALNY:US $ 184.01M 6.38M
Amarin AMRN:US $ 58.63M 13.76M
Biomarin Pharmaceutical BMRN:US $ 410.67M 8.28M
Chimerix CMRX:US 440K 539K
Emergent Biosolutions EBS:US $ 72.9M 78.7M
Exact Sciences EXAS:US $ 377.04M 25.17M
Exelixis EXEL:US $ 405.95M 63.17M
Glaxosmithkline GSK:US $ 4793M 1342M
Intercept Pharmaceuticals ICPT:US $ 71.45M 16.38M
IONIS PHARMACEUT IONS:US $ 129.05M 8.7M
JAZZ PHA JAZZ:US $ 808.67M 110.23M
Lonza Group LONN:SW 1.2B 129M
Merk MRK:US $ 10895M 328M
Moderna Inc MRNA:US 3.37B 1.68B
Myriad Genetics MYGN:US $ 129.6M 12.7M
Nektar Therapeutics NKTR:US $ 16.47M 3.04M
Neurocrine Biosciences NBIX:US $ 373.4M 67.4M
Opko Health OPK:US $ 115.58M 30.24M
Pacira Pharmaceuticals PCRX:US $ 118.78M 3.13M
Pfizer PFE:US $ 19071M 3420M
Ptc Therapeutics PTCT:US $ 155.89M 17.29M
Sarepta Therapeutics SRPT:US $ 195.69M 16.3M
Seattle Genetics SGEN:US $ 391.4M 52.57M
Teva Pharmaceutical Industries TEVA:US $ 1828M 26M
United Therapeutics UTHR:US $ 437.2M 1.2M